Back to Search Start Over

P125 Neoadjuvant pembrolizumab + chemotherapy vs placebo + chemotherapy followed by adjuvant pembrolizumab vs placebo for early TNBC: surgical outcomes from the phase 3 KEYNOTE-522 study.

Authors :
Kümmel, S.
Schmid, P.
Harbeck, N.
Takahashi, M.
Untch, M.
Boileau, J.-F.
Cortes, J.
McArthur, H.
Dent, R.
O'Shaughnessy, J.
Pusztai, L.
Foukakis, T.
Park, Y.H.
Hui, R.
Cardoso, F.
Denkert, C.
Zhu, Y.
Pan, W.
Karantza, V.
Fasching, P.
Source :
Breast; 2023 Supplement, Vol. 68, pS63-S64, 2p
Publication Year :
2023

Subjects

Subjects :
PEMBROLIZUMAB
PLACEBOS
CANCER chemotherapy

Details

Language :
English
ISSN :
09609776
Volume :
68
Database :
Supplemental Index
Journal :
Breast
Publication Type :
Academic Journal
Accession number :
162439806
Full Text :
https://doi.org/10.1016/S0960-9776(23)00242-4
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details